Live Forever Movement Draws Legal Heat
Tech entrepreneur Bryan Johnson built his brand around one bold idea: to live forever. Through Blueprint, his health start-up, Johnson promotes a daily regimen that includes dozens of supplements, strict diets, and constant biological testing. But behind the scenes, former employees are fighting back, claiming the company used confidentiality contracts to silence concerns about workplace practices.
Strict Contracts Surround Quest To Live Forever
To control his narrative, Johnson made confidentiality agreements a cornerstone of his operations. These contracts covered not just business data but also his personal life, including dating habits and home behavior. According to legal complaints, employees had little choice but to sign these documents if they wanted to stay employed.
Three former employees recently filed complaints with the National Labor Relations Board. They claim Johnson’s legal tactics violate federal laws protecting workers’ rights to discuss their jobs. One of them, Jamie Contento, said she signed out of fear but later challenged the terms after noticing behavior she found troubling.
Blueprint Markets The Dream To Live Forever
Blueprint’s marketing revolves around Johnson’s ambition to live forever. His face dominates the website, and his personal health stats drive product sales. He claims to have reversed his biological age by over five years.
Inside the company, however, some staff say the message doesn’t match the reality. Employees were asked to accept unusual behavior, including Johnson walking around partially nude or discussing sexual topics during work hours. A special “opt-in” agreement required them to say this conduct was not offensive or inappropriate.
Supplement Study Sparks Concerns
A paid Blueprint study tested its “longevity mix” and other products on 1,700 participants. Johnson promised to release the results in 2024, but internal data raised red flags. Around 60% of users reported side effects like nausea, bloating, and hormonal changes. Blood test results showed elevated blood sugar and lowered testosterone in many cases.
Dr. Oliver Zolman, Johnson’s longevity doctor, left the company after raising alarms. He refused to sign a follow-up NDA for severance. Other employees said they couldn’t speak out because their contracts restricted disclosure, even when health outcomes appeared questionable.
Business Stability At Odds With Live Forever Branding
While Johnson promotes Blueprint as one of the fastest-growing health brands for those who want to live forever, its finances tell a different story. Though the company brought in $40 million last year, it reportedly lost over $1 million per month and relied heavily on Johnson’s personal investment of $25 million.
Despite internal warnings, recruitment emails described Blueprint as “already profitable.” Employees say these misleading claims were protected by NDAs, preventing them from correcting the public narrative.
Former Fiancée’s Lawsuit Adds Pressure
Taryn Southern, a former fiancée and Kernel employee, sued Johnson after he fired her while she was battling Stage 3 cancer. Her lawsuit revealed that he demanded she sign a confidentiality agreement with a $500,000 penalty per violation. An arbitrator later enforced that agreement and ordered her to pay over $584,000 in legal fees.
Southern, now in remission, filed an NLRB complaint similar to those filed by former Blueprint staff. She said her silence hurt more than the cancer or the termination. Her case encouraged others to come forward, leading to a ripple of new legal actions against Johnson and his companies.
Questions Shadow The Live Forever Legacy
In 2023, Johnson told millions he had reversed aging, but internal test results showed his biological age sometimes increased. He claimed fluctuations were natural, but critics say he selectively highlights only favorable data.
This year, Johnson launched his own religion, “Don’t Die,” claiming it could save humanity. Yet as more legal and ethical challenges mount, his mission to live forever faces growing scrutiny—not only from regulators but from those who once helped build it.
